Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Year: 1997
Type: article
Source: PubMed
Authors: M A Guvakova, E Surmacz
Institution: Thomas Jefferson University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: IGF 1R IN BREAST CANCER
OpenAlex ID: W1497802607
